허지윤 기자

Heo Ji-yoon Staff writer, ScienceChosun News Desk

Total articles(371)
Yonsei Medical Center, Hana Bank team up to build senior welfare facility in Korea
Yonsei Medical Center, Hana Bank team up to build senior welfare facility in Korea
Yonsei Medical Center and Hana Bank are promoting the construction project of a silver town. Yonsei Medical Center announced on the 16th that it signed a multilateral business agreement with Hana Bank, MDI Future City Development, and YK Asset Management for the establishment of a senior welfare fac...
Japan advances stem cell research, promising treatment for Parkinson's disease
In the early 2000s, countries around the world competed to research stem cells, dubbed 'the flower of future medicine.' South Korea had an early start. In 2004, Dr. Hwang Woo-suk's team announced it had successfully cultivated the world's first cloned embryonic stem cells. However, when it was revea...
CMG Pharmaceutical secures FDA approval for schizophrenia treatment Mezofy
CHA Biotech subsidiary CMG Pharmaceutical announced on the 16th that it has obtained item approval for the schizophrenia treatment 'Mezofy' (formerly Depipzo) from the U.S. Food and Drug Administration (FDA). Mezofy is an oral film type schizophrenia treatment (active ingredient aripiprazole) develo...
U.S. Blocks NIH Medical Database Access for Some Countries, Excludes South Korea
The Korea Bio Association noted on the 16th that the National Institutes of Health (NIH) has blocked access to medical databases for certain countries of concern. The countries subject to the access ban include China, Hong Kong, Macau, Russia, Iran, North Korea, Cuba, and Venezuela. Attention is dra...
Pfizer halts danuglipron obesity drug development due to liver toxicity risks
U.S. pharmaceutical company Pfizer has declared a halt to the development of an oral obesity treatment. This decision comes after some patients in clinical trials experienced liver toxicity side effects. Given that oral medications are expected to change the dynamics of the obesity treatment market,...
Nudge Healthcare expands into mental health market through acquisitions in South Korea
Digital healthcare corporations managing meals and lifestyles are recently pushing for mergers and acquisitions (M&A) and making various attempts, such as partnering with pharmaceutical and insurance companies. They are diversifying their businesses and exploring new markets as they have reached a g...
Celltrion gains U.S. FDA approval for Yuflyma’s interchangeability status
Celltrion announced on the 14th that it has obtained approval from the U.S. Food and Drug Administration (FDA) for the interchangeability change of its autoimmune disease treatment Yuflyma (ingredient name adalimumab) and the original medication Humira. According to the U.S. interchangeability syste...
Korea advances research on Parkinson's disease with stem cell therapy and exercise
April 11 is World Parkinson's Day. Parkinson's disease, characterized by tremors in the hands and feet and gradual paralysis of the body, is considered one of the three major geriatric brain disorders alongside dementia and stroke. With the intensification of aging, the number of Parkinson's disease...
B-type influenza cases surge among children and adolescents in South Korea
Influenza type B is currently prevalent among children and adolescents aged 7 to 18. The Korea Disease Control and Prevention Agency noted that in the 14th week of this year, the number of suspected influenza cases at outpatient medical institutions was 16.9 per 1,000 outpatients, showing an increas...
Novartis invests $33 trillion won in U.S. factories amid tariff pressures
Swiss pharmaceutical company Novartis announced that it will invest 33 trillion won to build a new factory in the United States. Following this year, when American pharmaceutical companies Eli Lilly and Johnson & Johnson (J&J) announced large-scale investment plans in the U.S., major European pharma...
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10